Rating History for MEI Pharma (MEIP) by Brookline Capital Markets

More Stocks Rated by Brookline Capital Markets | Latest Ratings for MEIP
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/22/2024 Leah Rush Cann Downgrade Hold
(Buy)		 N/A
(N/A)		 2.86
(3.07)		 7.34% Details